Dissecting the multifaceted roles of autophagy in cancer initiation, growth, and metastasis: from molecular mechanisms to therapeutic applications
- PMID: 38902544
- DOI: 10.1007/s12032-024-02417-2
Dissecting the multifaceted roles of autophagy in cancer initiation, growth, and metastasis: from molecular mechanisms to therapeutic applications
Abstract
Autophagy is a cytoplasmic defense mechanism that cells use to break and reprocess their intracellular components. This utilization of autophagy is regarded as a savior in nutrient-deficient and other stressful conditions. Hence, autophagy keeps contact with and responds to miscellaneous cellular tensions and diverse pathways of signal transductions, such as growth signaling and cellular death. Importantly, autophagy is regarded as an effective tumor suppressor because regular autophagic breakdown is essential for cellular maintenance and minimizing cellular damage. However, paradoxically, autophagy has also been observed to promote the events of malignancies. This review discussed the dual role of autophagy in cancer, emphasizing its influence on tumor survival and progression. Possessing such a dual contribution to the malignant establishment, the prevention of autophagy can potentially advocate for the advancement of malignant transformation. In contrast, for the context of the instituted tumor, the agents of preventing autophagy potently inhibit the advancement of the tumor. Key regulators, including calpain 1, mTORC1, and AMPK, modulate autophagy in response to nutritional conditions and stress. Oncogenic mutations like RAS and B-RAF underscore autophagy's pivotal role in cancer development. The review also delves into autophagy's context-dependent roles in tumorigenesis, metastasis, and the tumor microenvironment (TME). It also discusses the therapeutic effectiveness of autophagy for several cancers. The recent implication of autophagy in the control of both innate and antibody-mediated immune systems made it a center of attention to evaluating its role concerning tumor antigens and treatments of cancer.
Keywords: Autophagosome; Autophagy; Cancer immunotherapy; Epithelial to mesenchymal transition; Metastatic-cascade; Tumor antigens; Tumor microenvironment; Tumorigenesis.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
The Evolving, Multifaceted Roles of Autophagy in Cancer.Adv Cancer Res. 2016;130:1-53. doi: 10.1016/bs.acr.2016.01.005. Epub 2016 Feb 23. Adv Cancer Res. 2016. PMID: 27037750 Review.
-
Active autophagy in cancer-associated fibroblasts: Recent advances in understanding the novel mechanism of tumor progression and therapeutic response.J Cell Physiol. 2021 Nov;236(11):7887-7902. doi: 10.1002/jcp.30419. Epub 2021 May 18. J Cell Physiol. 2021. PMID: 34008184 Review.
-
Interaction between tumor microenvironment, autophagy, and epithelial-mesenchymal transition in tumor progression.Cancer Treat Res Commun. 2022;32:100592. doi: 10.1016/j.ctarc.2022.100592. Epub 2022 Jun 13. Cancer Treat Res Commun. 2022. PMID: 35728404 Review.
-
Inflammatory signaling cascades and autophagy in cancer.Autophagy. 2018;14(2):190-198. doi: 10.1080/15548627.2017.1345412. Epub 2017 Sep 18. Autophagy. 2018. PMID: 28813180 Free PMC article. Review.
-
Emerging role of autophagy in anti-tumor immunity: Implications for the modulation of immunotherapy resistance.Drug Resist Updat. 2021 May;56:100752. doi: 10.1016/j.drup.2021.100752. Epub 2021 Feb 16. Drug Resist Updat. 2021. PMID: 33765484 Review.
Cited by
-
Harnessing the role of aberrant cell signaling pathways in glioblastoma multiforme: a prospect towards the targeted therapy.Mol Biol Rep. 2024 Oct 19;51(1):1069. doi: 10.1007/s11033-024-09996-3. Mol Biol Rep. 2024. PMID: 39424705 Review.
-
Molecular mechanisms and clinical significance of perineural invasion in malignancies: the pivotal role of tumor-associated Schwann cells in cancer progression and metastasis.Med Oncol. 2025 Apr 22;42(5):171. doi: 10.1007/s12032-025-02729-x. Med Oncol. 2025. PMID: 40259163 Review.
-
Helicobacter pylori and gastric cancer: mechanisms and new perspectives.J Hematol Oncol. 2025 Jan 23;18(1):10. doi: 10.1186/s13045-024-01654-2. J Hematol Oncol. 2025. PMID: 39849657 Free PMC article. Review.
References
-
- Butler DE, Marlein C, Walker HF, Frame FM, Mann VM, Simms MS, Davies BR, Collins AT, Maitland NJ. Inhibition of the PI3K/AKT/mTOR pathway activates autophagy and compensatory Ras/Raf/MEK/ERK signalling in prostate cancer. Oncotarget. 2017. https://doi.org/10.18632/oncotarget.18082 . - DOI - PubMed - PMC
-
- Nakahira K, Cloonan SM, Mizumura K, Choi AMK, Ryter SW. Autophagy: a crucial moderator of redox balance, inflammation, and apoptosis in lung disease. Antioxid Redox Signal. 2014. https://doi.org/10.1089/ars.2013.5373 . - DOI - PubMed - PMC
-
- Ryter SW, Cloonan SM, Choi AMK. Autophagy: a critical regulator of cellular metabolism and homeostasis. Mol Cells. 2013. https://doi.org/10.1007/s10059-013-0140-8 . - DOI - PubMed - PMC
-
- Takamura A, Komatsu M, Hara T, Sakamoto A, Kishi C, Waguri S, Eishi Y, Hino O, Tanaka K, Mizushima N. Autophagy-deficient mice develop multiple liver tumors. Genes Dev. 2011. https://doi.org/10.1101/gad.2016211 . - DOI - PubMed - PMC
-
- Xia HG, Zhang L, Chen G, Zhang T, Liu J, Jin M, Xiuquan M, Dawei M, Yuan J. Control of basal autophagy by calpain1 mediated cleavage of ATG5. Autophagy. 2010. https://doi.org/10.4161/auto.6.1.10326 . - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous